5 major NRs in the next 6 months... and smaller ones
We should see REX I data this week or next. but it is insigificant... Focalin sales are and that is NR 1.... the remaining four include 3 ANDAs - Eff, Prot, and Gluc... each of which, assuming positive, will spike the SP. Focalin sales will push the SP north and sustain it. The big one is the REX partnership and we will see 4-5$ per share in cash.